RxDoctor Payments Data

Kamal Gandhi

Nephrology · Granada Hills, CANPI 1972510485

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Novartis at 34.2% of the total. That places this record below the midpoint for nephrology clinicians in CA, where the typical reported total is $1,018.

$298in general payments, 2019–2025

Across 5 payments — averaging $59.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$102
  • Gilead$96
  • Boston Scientific$64
  • Otsuka America Pharmaceutical, Inc.$21
  • Lilly USA, LLC$15
$1,306,575in research payments, 2019–2025

Across 790 payments — averaging $1653.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Akebia Therapeutics Inc$1.1M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$121K
  • Gilead$82K
  • GSK$19K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$18K
  • Boehringer Ingelheim International GmbH$9K

What the payments were for

  • Food & beverage$298100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$298 in reported general payments places this provider in the 30th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California

Other nephrology in Granada Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →